Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 14706852 
Chitaley K, et al. (2004) Vasodilator-stimulated phosphoprotein is a substrate for protein kinase C. FEBS Lett 556, 211-5 14706852
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Download Sites

S154-p - VASP (rat)
Orthologous residues
VASP (human): S157‑p, VASP (mouse): S153‑p, VASP (rat): S154‑p
Characterization
 Methods used to characterize site in vivo electrophoretic mobility shift, phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  'muscle, smooth'-'heart, artery'
 Cellular systems studied:  primary cells
 Species studied:  rat
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE PKCA (rat)
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKCA (rat) pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
serum increase
forskolin increase
8-Rp-cAMP forskolin inhibit treatment-induced decrease
SNAP increase
Rp-cGMP SNAP inhibit treatment-induced increase
phorbol ester increase
GF109203X phorbol ester inhibit treatment-induced increase
Go 6976 phorbol ester inhibit treatment-induced increase
Go 6983 phorbol ester inhibit treatment-induced increase


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.